Peter Alperin

Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis

Richard Kahn, Peter Alperin, David Eddy et al. · The Lancet · 2010 · 286 citations

Medicine, Pharmacoeconomics, Preventive Medicine +13

Modeling effects of <scp>SGLT</scp>‐2 inhibitor dapagliflozin treatment versus standard diabetes therapy on cardiovascular and microvascular outcomes

Julia Dziuba, Peter Alperin, J. Racketa et al. · Diabetes Obesity and Metabolism · 2014 · 96 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Cytogenetic damage induced by folate deficiency in mice is enhanced by caffeine.

James T. MacGregor, Robert Schlegel, Carol M. Wehr et al. · Proceedings of the National Academy of Sciences · 1990 · 86 citations

Agriculture, Nutrition, Nutritional Sciences +17

Health Benefits and Cost-effectiveness of a Hybrid Screening Strategy for Colorectal Cancer

Tuan Dinh, Uri Ladabaum, Peter Alperin et al. · Clinical Gastroenterology and Hepatology · 2013 · 51 citations

Medicine, Pharmacoeconomics, Preventive Medicine +15

A Standardized Vascular Disease Health Check in Europe: A Cost-Effectiveness Analysis

C. Andy Schuetz, Peter Alperin, Swathi Guda et al. · PLoS ONE · 2013 · 41 citations · Full text

Pharmacy, Cardiology, Pharmacoeconomics +17